[HTML][HTML] Delayed graft function in the kidney transplant

A Siedlecki, W Irish, DC Brennan - American journal of transplantation, 2011 - Elsevier
Acute kidney injury occurs with kidney transplantation and too frequently progresses to the
clinical diagnosis of delayed graft function (DGF). Poor kidney function in the first week of …

Nitric oxide and peroxynitrite in health and disease

P Pacher, JS Beckman, L Liaudet - Physiological reviews, 2007 - journals.physiology.org
The discovery that mammalian cells have the ability to synthesize the free radical nitric oxide
(NO) has stimulated an extraordinary impetus for scientific research in all the fields of …

Metabolic reprogramming in macrophage responses

Y Liu, R Xu, H Gu, E Zhang, J Qu, W Cao, X Huang… - Biomarker …, 2021 - Springer
Macrophages are critical mediators of tissue homeostasis, with the function of tissue
development and repair, but also in defense against pathogens. Tumor-associated …

Delayed graft function in kidney transplantation

N Perico, D Cattaneo, MH Sayegh, G Remuzzi - The Lancet, 2004 - thelancet.com
Delayed graft function is a form of acute renal failure resulting in post-transplantation
oliguria, increased allograft immunogenicity and risk of acute rejection episodes, and …

Therapeutic applications of PARP inhibitors: anticancer therapy and beyond

NJ Curtin, C Szabo - Molecular aspects of medicine, 2013 - Elsevier
The aim of this article is to describe the current and potential clinical translation of
pharmacological inhibitors of poly (ADP-ribose) polymerase (PARP) for the therapy of …

Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseases

NA Berger, VC Besson, AH Boulares… - British journal of …, 2018 - Wiley Online Library
The recent clinical availability of the PARP inhibitor olaparib (Lynparza) opens the door for
potential therapeutic repurposing for non‐oncological indications. Considering (a) the …

[HTML][HTML] Myeloperoxidase in kidney disease

E Malle, T Buch, HJ Grone - Kidney international, 2003 - Elsevier
Myeloperoxidase in kidney disease. In glomerular and tubulointerstitial disease,
polymorphonuclear-and monocyte-derived reactive oxygen species may contribute to …

Renal Nano-drug delivery for acute kidney Injury: Current status and future perspectives

HN Geo, DD Murugan, Z Chik, A Norazit, YY Foo… - Journal of Controlled …, 2022 - Elsevier
Acute kidney injury (AKI) causes considerable morbidity and mortality, particularly in the
case of post-cardiac infarction or kidney transplantation; however, the site-specific …

Arginine‐based inhibitors of nitric oxide synthase: therapeutic potential and challenges

J Víteček, A Lojek, G Valacchi… - Mediators of …, 2012 - Wiley Online Library
In the past three decades, nitric oxide has been well established as an important bioactive
molecule implicated in regulation of cardiovascular, nervous, and immune systems …

Acute renal failure in the newborn

SP Andreoli - Seminars in perinatology, 2004 - Elsevier
Acute renal failure in the newborn is a common problem and is typically classified as
prerenal, intrinsic renal disease including vascular insults, and obstructive uropathy. In the …